Mobile

A trial comparing effect and safety of insulin degludec/insulin aspart vs. insulin glargine plus insulin aspart in subjects with type 2 diabetes treated with basal insulin with or without oral antidia...

Mise à jour : Il y a 4 ans
Référence : U1111-1175-7895

A trial comparing effect and safety of insulin degludec/insulin aspart vs. insulin glargine plus insulin aspart in subjects with type 2 diabetes treated with basal insulin with or without oral antidiabetic treatment in need of treatment intensification 38týdenní studie srovnávající účinnost a bezpečnost inzulínu degludec / inzulínu aspart a inzulínu glargin + inzulínu aspart u subjektů s diabetem 2. typu na bazálním inzulínu s perorálními antidiabetiky či bez nich vyžadujících intenzifikaci léčby

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To confirm the effect of insulin degludec/insulin aspart once daily versus insulin glargine once daily in combination with insulin aspart once daily in controlling glycaemia after 26 weeks in subjects with type 2 diabetes mellitus treated with basal insulin with or without oral antidiabetic treatment in need of treatment intensification

Critère d'inclusion

  • Diabetes Mellitus, Type 2,Diabetes mellitus Typ 2

Liens